Clinical trial
A Clinical Trial to Prevent the Complications of Insulin Resistance (Including…
NCT00015626 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00015626 |
|---|---|
| Title | A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes) |
| Official title | A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes) |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Insulin Resistance, Diabetes Mellitus |
| Intervention type | Behavioral, Drug, Procedure |
| Interventions | Metformin, skin biopsy, diet and exercise, pioglitazone, rosiglitazone |
| Enrollment | 300 |
| First posted | Apr 26, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: